Please try another search
EXINI Diagnostics AB (publ) provides various solutions for medical decision support to hospitals worldwide. The company offers software products, including EXINI bone for diagnosing prostate cancer and analyzing bone scintigraphy; EXINI heart that provides analysis of myocardial perfusion scintigraphy; EXINI brain for diagnosing dementia by processing cerebral blood flow scans; and EXINI that analyses myocardial perfusion scintigraphy. EXINI Diagnostics AB (publ) has a collaboration with the Prostate Cancer Clinical Trials Consortium (PCCTC). The company was formerly known as WeAidU AB and changed its name to EXINI Diagnostics AB (publ) in 2007. EXINI Diagnostics AB (publ) was founded in 1999 and is based in Lund, Sweden. EXINI Diagnostics AB (publ) operates as a subsidiary of Progenics Pharmaceuticals, Inc.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review